Flatiron Health vs Recursion

Flatiron Health specializes in extracting insights from real-world oncology patient data to support clinical decisions and research, making it valuable for both care providers and pharma companies doing post-market analysis. Recursion focuses on early-stage drug discovery through massive-scale biological experimentation and AI modeling, operating an automated lab that generates proprietary multi-omic datasets to find novel drug candidates. The key difference is their position in the drug lifecycle: Flatiron analyzes real-world outcomes from existing treatments while Recursion discovers new molecules in the lab. Flatiron offers an API for integration while Recursion's platform remains proprietary to their internal discovery efforts.